Post-ECCMID Symposium
Advances in PK/PD
Vienna, Austria, April 13, 2010; 15.00-18.00

Location: Le Méridien, Opernring 13, 1010 Vienna, Austria.

Invitation


Enjoy Vienna ...

Program:

15.00-15.10 U. Theuretzbacher
Markus Müller
Welcome and Introduction
15.10-15.35 A. MacGowan PK/PD and prevention of resistance
15.35-16.05 U. Theuretzbacher
H. Derendorf
Protein binding: planned publication
Protein binding: Late breaker results
16.05-16.30 Break
16.30-17.50 PK/PD of potentiator combinations
  M. Dudley
M. Zeitlinger
G. Drusano
J. Mouton

PK/PD aspects of bacterial efflux–pump inhibitors
PK/PD aspects of eucaryotic efflux–pumps and inhibitors
PK/PD of new beta-lactamase inhibitor combinations
PK/PD challenges in the development of ß-lactamase inhibitor combinations
17.55-18.00 A. MacGowan
(ISAP president elect)
Conclusion



Planning Committee:
U. Theuretzbacher, PhD Center for Anti-Infective Agents, Vienna, Austria
M. Zeitlinger, MD Medical Univ. Vienna, Austria
M. Müller, MD Medical Univ. Vienna, Austria
Faculty:
H. Derendorf, PhD; Univ. of Florida, Gainesville, FL. USA
G. Drusano, MD; Ordway Research, Albany, NY, USA
M. Dudley, Pharm.D.; Mpex Pharmaceuticals, San Diego, CA, USA
A. MacGowan, MD; Bristol Center for Antimicrobial Research, Bristol, UK
J. Mouton, MD, PhD; Radboud University Nijmegen Medical Center, Nijmegen, NL
M. Müller, MD; Medical Univ. Vienna, Vienna, Austria
U. Theuretzbacher, PhD; Center for Anti-Infective Agents, Vienna, Austria
M. Zeitlinger, MD; Medical Univ. Vienna, Vienna, Austria

Registration on site:

- ISAP members: free
- Students: free
- Non-members: 100 Euro including one year ISAP membership, beverages, coffee, cookies


Back to ISAP home page


Credits